Načítá se...
Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective
OBJECTIVES: To estimate the cost-effectiveness of ranolazine when added to standard-of-care (SoC) antianginals compared with SoC alone in patients with stable coronary disease experiencing ≥3 attacks/week. SETTING: An economic model utilising a UK health system perspective, a 1-month cycle-length an...
Uloženo v:
| Vydáno v: | BMJ Open |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4636621/ https://ncbi.nlm.nih.gov/pubmed/26546142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-008861 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|